HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genetic Features of HIV-1 Integrase Sub-Subtype A6 Predominant in Russia and Predicted Susceptibility to INSTIs.

Abstract
The increasing use of the integrase strand transfer inhibitor (INSTI) class for the treatment of HIV-infection has pointed to the importance of analyzing the features of HIV-1 subtypes for an improved understanding of viral genetic variability in the occurrence of drug resistance (DR). In this study, we have described the prevalence of INSTI DR in a Russian cohort and the genetic features of HIV-1 integrase sub-subtype A6. We included 408 HIV infected patients who were not exposed to INSTI. Drug resistance mutations (DRMs) were detected among 1.3% of ART-naïve patients and among 2.7% of INSTI-naïve patients. The prevalence of 12 polymorphic mutations was significantly different between sub-subtypes A6 and A1. Analysis of the genetic barriers determined two positions in which subtype A (A1 and A6) showed a higher genetic barrier (G140C and V151I) compared with subtype B, and one position in which subtypes A1 and B displayed a higher genetic barrier (L74M and L74I) than sub-subtype A6. Additionally, we confirmed that the L74I mutation was selected at the early stage of the epidemic and subsequently spread as a founder effect in Russia. Our data have added to the overall understanding of the genetic features of sub-subtype A6 in the context of drug resistance.
AuthorsAlina Kirichenko, Ilya Lapovok, Pavel Baryshev, David A M C van de Vijver, Jeroen J A van Kampen, Charles A B Boucher, Dimitrios Paraskevis, Dmitry Kireev
JournalViruses (Viruses) Vol. 12 Issue 8 (07 31 2020) ISSN: 1999-4915 [Electronic] Switzerland
PMID32752001 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HIV Integrase Inhibitors
  • HIV Integrase
Topics
  • Adult
  • Drug Resistance, Viral (genetics)
  • Female
  • Genotype
  • HIV Infections (drug therapy, epidemiology)
  • HIV Integrase (classification, genetics)
  • HIV Integrase Inhibitors (pharmacology)
  • HIV-1 (drug effects, enzymology)
  • Humans
  • Male
  • Mutation
  • Phylogeny
  • Polymorphism, Genetic
  • Prevalence
  • Russia
  • Sequence Analysis, DNA

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: